AU2020246221A1 - Cell analysis method, training method for deep learning algorithm, cell analysis device, training apparatus for deep learning algorithm, cell analysis program, and training program for deep learning algorithm - Google Patents
Cell analysis method, training method for deep learning algorithm, cell analysis device, training apparatus for deep learning algorithm, cell analysis program, and training program for deep learning algorithm Download PDFInfo
- Publication number
- AU2020246221A1 AU2020246221A1 AU2020246221A AU2020246221A AU2020246221A1 AU 2020246221 A1 AU2020246221 A1 AU 2020246221A1 AU 2020246221 A AU2020246221 A AU 2020246221A AU 2020246221 A AU2020246221 A AU 2020246221A AU 2020246221 A1 AU2020246221 A1 AU 2020246221A1
- Authority
- AU
- Australia
- Prior art keywords
- cell
- signal
- cells
- deep learning
- learning algorithm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004458 analytical method Methods 0.000 title claims abstract description 165
- 238000013135 deep learning Methods 0.000 title claims abstract description 153
- 238000000034 method Methods 0.000 title claims abstract description 130
- 238000004422 calculation algorithm Methods 0.000 title claims abstract description 129
- 238000012549 training Methods 0.000 title claims description 142
- 238000013528 artificial neural network Methods 0.000 claims abstract description 65
- 239000012472 biological sample Substances 0.000 claims abstract description 63
- 210000004027 cell Anatomy 0.000 claims description 516
- 238000012545 processing Methods 0.000 claims description 140
- 238000005259 measurement Methods 0.000 claims description 138
- 230000008569 process Effects 0.000 claims description 90
- 239000000523 sample Substances 0.000 claims description 68
- 210000004369 blood Anatomy 0.000 claims description 46
- 239000008280 blood Substances 0.000 claims description 46
- 238000004364 calculation method Methods 0.000 claims description 28
- 210000002700 urine Anatomy 0.000 claims description 25
- 230000002159 abnormal effect Effects 0.000 claims description 19
- 210000000440 neutrophil Anatomy 0.000 claims description 19
- 210000004698 lymphocyte Anatomy 0.000 claims description 17
- 238000004590 computer program Methods 0.000 claims description 13
- 210000003924 normoblast Anatomy 0.000 claims description 13
- 210000002935 megaloblast Anatomy 0.000 claims description 12
- 210000003651 basophil Anatomy 0.000 claims description 11
- 210000001616 monocyte Anatomy 0.000 claims description 9
- 210000003979 eosinophil Anatomy 0.000 claims description 8
- 210000003714 granulocyte Anatomy 0.000 claims description 8
- 210000004881 tumor cell Anatomy 0.000 claims description 8
- 210000004005 intermediate erythroblast Anatomy 0.000 claims description 4
- 210000004180 plasmocyte Anatomy 0.000 claims description 4
- 210000000468 rubriblast Anatomy 0.000 claims description 4
- 210000003593 megakaryocyte Anatomy 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 59
- 230000006870 function Effects 0.000 description 57
- 238000007405 data analysis Methods 0.000 description 53
- 238000006243 chemical reaction Methods 0.000 description 28
- 238000010586 diagram Methods 0.000 description 27
- 210000003743 erythrocyte Anatomy 0.000 description 24
- 239000000306 component Substances 0.000 description 17
- 239000000975 dye Substances 0.000 description 17
- 210000000601 blood cell Anatomy 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 16
- 210000001124 body fluid Anatomy 0.000 description 14
- 239000010839 body fluid Substances 0.000 description 14
- 210000000265 leukocyte Anatomy 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 210000001772 blood platelet Anatomy 0.000 description 12
- 238000011478 gradient descent method Methods 0.000 description 10
- 230000002949 hemolytic effect Effects 0.000 description 10
- 239000004094 surface-active agent Substances 0.000 description 10
- 238000000684 flow cytometry Methods 0.000 description 9
- 210000005259 peripheral blood Anatomy 0.000 description 9
- 239000011886 peripheral blood Substances 0.000 description 9
- 210000000170 cell membrane Anatomy 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical group 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 239000012128 staining reagent Substances 0.000 description 8
- 230000003321 amplification Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 239000004065 semiconductor Substances 0.000 description 7
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 6
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 6
- 230000004913 activation Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 210000002919 epithelial cell Anatomy 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 230000003204 osmotic effect Effects 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 238000007621 cluster analysis Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001360 synchronised effect Effects 0.000 description 4
- 206010025323 Lymphomas Diseases 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 238000007430 reference method Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- 206010000871 Acute monocytic leukaemia Diseases 0.000 description 2
- 206010000890 Acute myelomonocytic leukaemia Diseases 0.000 description 2
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 2
- 208000036566 Erythroleukaemia Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 208000017604 Hodgkin disease Diseases 0.000 description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 208000035490 Megakaryoblastic Acute Leukemia Diseases 0.000 description 2
- 208000035489 Monocytic Acute Leukemia Diseases 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- 201000003793 Myelodysplastic syndrome Diseases 0.000 description 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
- 208000033835 Myelomonocytic Acute Leukemia Diseases 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 208000002151 Pleural effusion Diseases 0.000 description 2
- 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 2
- 208000021841 acute erythroid leukemia Diseases 0.000 description 2
- 208000013593 acute megakaryoblastic leukemia Diseases 0.000 description 2
- 208000020700 acute megakaryocytic leukemia Diseases 0.000 description 2
- 208000011912 acute myelomonocytic leukemia M4 Diseases 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 210000000267 erythroid cell Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000010365 information processing Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 210000001237 metamyelocyte Anatomy 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000001167 myeloblast Anatomy 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 210000000633 nuclear envelope Anatomy 0.000 description 2
- 210000004765 promyelocyte Anatomy 0.000 description 2
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
- 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013136 deep learning model Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000003219 hemolytic agent Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 210000005074 megakaryoblast Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000005033 mesothelial cell Anatomy 0.000 description 1
- 210000003003 monocyte-macrophage precursor cell Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- -1 urine Substances 0.000 description 1
- 210000003741 urothelium Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48785—Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply
- G01N33/48792—Data management, e.g. communication with processing unit
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0205—Investigating particle size or size distribution by optical means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/045—Combinations of networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/08—Learning methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/016—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/018—Platelets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N2015/0294—Particle shape
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1434—Optical arrangements
- G01N2015/144—Imaging characterised by its optical setup
- G01N2015/1443—Auxiliary imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1493—Particle size
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1497—Particle shape
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/048—Activation functions
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Evolutionary Computation (AREA)
- Hematology (AREA)
- Mathematical Physics (AREA)
- General Engineering & Computer Science (AREA)
- Computing Systems (AREA)
- Data Mining & Analysis (AREA)
- Computational Linguistics (AREA)
- Artificial Intelligence (AREA)
- Software Systems (AREA)
- Urology & Nephrology (AREA)
- Signal Processing (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Databases & Information Systems (AREA)
- Medical Informatics (AREA)
- Optics & Photonics (AREA)
- Human Computer Interaction (AREA)
- Ecology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019-055385 | 2019-03-22 | ||
| JP2019055385A JP7352365B2 (ja) | 2019-03-22 | 2019-03-22 | 細胞の分析方法、深層学習アルゴリズムの訓練方法、細胞分析装置、深層学習アルゴリズムの訓練装置、細胞の分析プログラム及び深層学習アルゴリズムの訓練プログラム |
| PCT/JP2020/011596 WO2020196074A1 (fr) | 2019-03-22 | 2020-03-17 | Procédé d'analyse de cellule, procédé d'apprentissage pour algorithme d'apprentissage profond, dispositif d'analyse de cellule, procédé d'apprentissage pour algorithme d'apprentissage profond, programme d'analyse de cellule et programme d'apprentissage pour algorithme d'apprentissage profond |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020246221A1 true AU2020246221A1 (en) | 2021-11-11 |
Family
ID=72558707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020246221A Pending AU2020246221A1 (en) | 2019-03-22 | 2020-03-17 | Cell analysis method, training method for deep learning algorithm, cell analysis device, training apparatus for deep learning algorithm, cell analysis program, and training program for deep learning algorithm |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220003745A1 (fr) |
| EP (1) | EP3943933A4 (fr) |
| JP (2) | JP7352365B2 (fr) |
| CN (1) | CN113574380A (fr) |
| AU (1) | AU2020246221A1 (fr) |
| WO (1) | WO2020196074A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102533080B1 (ko) * | 2020-09-25 | 2023-05-15 | 고려대학교 산학협력단 | 선 레이블을 이용한 세포 영상 분할 방법, 이를 수행하기 위한 기록 매체 및 장치 |
| US20220230709A1 (en) * | 2021-01-15 | 2022-07-21 | Sanofi | Sensing of biological cells in a sample for cell type identification |
| JP7374943B2 (ja) | 2021-02-26 | 2023-11-07 | シスメックス株式会社 | 表示方法および検体分析装置 |
| EP4060319A1 (fr) * | 2021-03-12 | 2022-09-21 | Sysmex Corporation | Procédé d'analyse et analyseur |
| JPWO2023282026A1 (fr) * | 2021-07-09 | 2023-01-12 | ||
| US20230338953A1 (en) * | 2022-03-17 | 2023-10-26 | Sysmex Corporation | Specimen analyzer, specimen analysis method, and program |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63180836A (ja) | 1987-01-21 | 1988-07-25 | Japan Spectroscopic Co | 粒子デ−タ解析装置 |
| ES2278566T3 (es) | 1994-10-20 | 2007-08-16 | Sysmex Corporation | Reactivo y metodo para analizar componentes solidos en la orina. |
| JP2001174456A (ja) | 1999-12-20 | 2001-06-29 | Toyobo Co Ltd | 白血球細分類装置および白血球の細分類方法 |
| JP3837006B2 (ja) | 2000-03-22 | 2006-10-25 | シスメックス株式会社 | 細菌の染色方法及び検出方法 |
| US7309581B2 (en) | 2000-11-01 | 2007-12-18 | Sysmex Corporation | Method of staining, detection and counting bacteria, and a diluent for bacterial stain |
| JP6001425B2 (ja) * | 2012-11-26 | 2016-10-05 | シスメックス株式会社 | 血球分析方法、血球分析装置およびプログラム |
| US20170052106A1 (en) | 2014-04-28 | 2017-02-23 | The Broad Institute, Inc. | Method for label-free image cytometry |
| JP6661278B2 (ja) | 2015-03-27 | 2020-03-11 | シスメックス株式会社 | 血液分析装置および血液分析方法 |
| WO2017053592A1 (fr) | 2015-09-23 | 2017-03-30 | The Regents Of The University Of California | Apprentissage profond dans le domaine de la classification des cellules non labellisées et extraction de particules par vision par ordinateur |
| CN108351289B (zh) | 2015-10-28 | 2021-11-26 | 国立大学法人东京大学 | 分析装置 |
| JP2017219479A (ja) | 2016-06-09 | 2017-12-14 | 住友電気工業株式会社 | 微小粒子計測装置及び分析方法 |
| JP7104691B2 (ja) | 2016-08-22 | 2022-07-21 | アイリス インターナショナル， インコーポレイテッド | 生体粒子の分類のシステム及び方法 |
| WO2018203568A1 (fr) | 2017-05-02 | 2018-11-08 | シンクサイト株式会社 | Système et procédé d'évaluation de cellules et programme d'évaluation de cellules |
-
2019
- 2019-03-22 JP JP2019055385A patent/JP7352365B2/ja active Active
-
2020
- 2020-03-17 CN CN202080021358.6A patent/CN113574380A/zh active Pending
- 2020-03-17 AU AU2020246221A patent/AU2020246221A1/en active Pending
- 2020-03-17 EP EP20778791.2A patent/EP3943933A4/fr active Pending
- 2020-03-17 WO PCT/JP2020/011596 patent/WO2020196074A1/fr active Search and Examination
-
2021
- 2021-09-21 US US17/480,683 patent/US20220003745A1/en active Pending
-
2023
- 2023-09-11 JP JP2023147139A patent/JP2023164555A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220003745A1 (en) | 2022-01-06 |
| JP2023164555A (ja) | 2023-11-10 |
| JP2020153946A (ja) | 2020-09-24 |
| EP3943933A1 (fr) | 2022-01-26 |
| CN113574380A (zh) | 2021-10-29 |
| JP7352365B2 (ja) | 2023-09-28 |
| EP3943933A4 (fr) | 2022-12-28 |
| WO2020196074A1 (fr) | 2020-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020246221A1 (en) | Cell analysis method, training method for deep learning algorithm, cell analysis device, training apparatus for deep learning algorithm, cell analysis program, and training program for deep learning algorithm | |
| US10222320B2 (en) | Identifying and enumerating early granulated cells (EGCs) | |
| EP3073265B1 (fr) | Analyseur de sang et procédé d'analyse de sang | |
| Schapkaitz et al. | Performance evaluation of the new measurement channels on the automated Sysmex XN-9000 hematology analyzer | |
| JP2016528506A (ja) | 分類を支援するための分析法 | |
| CN105980852A (zh) | 细胞分析方法和系统、装置 | |
| US20230221238A1 (en) | Cell analysis method and cell analyzer | |
| CN114450589A (zh) | 分析血液样本中红细胞方法及血液分析系统 | |
| KR20190088403A (ko) | 대장 직장암 환자와 정상인의 말초혈액 내 면역세포의 분포 차이를 이용하여 면역력을 평가하고 암 발병 유무에 대한 정보를 제공하는 방법 및 이를 이용한 진단키트 | |
| RU2820983C2 (ru) | Способ клеточного анализа, способ обучения для алгоритма глубокого обучения, устройство клеточного анализа, обучающее устройство для алгоритма глубокого обучения, программа клеточного анализа и обучающая программа для алгоритма глубокого обучения | |
| US20230314300A1 (en) | Cell analysis method and cell analyzer | |
| KR101847778B1 (ko) | 이분형 로지스틱 회귀분석 알고리즘을 적용한 말초혈액 면역력 평가 및 암 발병 유무에 대한 정보를 제공하는 방법 및 이를 이용한 진단키트 | |
| JPWO2020137640A1 (ja) | 血液分析装置、コンピュータープログラム、および血液分析方法 | |
| EP4246123A1 (fr) | Analyseur d'échantillon, procédé d'analyse d'échantillon et programme | |
| JP2023137001A (ja) | 検体分析装置、検体分析方法およびプログラム | |
| JP2023137000A (ja) | 検体分析装置、検体分析方法およびプログラム | |
| KR101847779B1 (ko) | 이분형 로지스틱 회귀분석 알고리즘을 적용하여 말초혈액 면역력을 단계별로 구분하여 평가하고 암 발병 유무에 대한 정보를 제공하는 방법 및 이를 이용한 진단키트 | |
| Graindor et al. | Performance evaluation of the Spinit®-BC, a new point-of-care assay for total WBC count with 5-part differential and hematocrit measurement. | |
| CN117501127A (zh) | 一种样本分析装置和样本分析方法 | |
| Lambert et al. | Performance of spectral flow cytometry and mass cytometry for the study of innate myeloid cell populations | |
| CN115843332A (zh) | 一种样本分析装置和样本分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ CELL ANALYSIS METHOD, TRAINING METHOD FOR DEEP LEARNING ALGORITHM, CELL ANALYSIS DEVICE, TRAINING APPARATUS FOR DEEP LEARNING ALGORITHM, CELL ANALYSIS PROGRAM, AND TRAINING PROGRAM FOR DEEP LEARNING ALGORITHM |